These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15161652)

  • 1. Kinetics of gene expression in murine cutaneous graft-versus-host disease.
    Sugerman PB; Faber SB; Willis LM; Petrovic A; Murphy GF; Pappo J; Silberstein D; van den Brink MR
    Am J Pathol; 2004 Jun; 164(6):2189-202. PubMed ID: 15161652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
    Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
    J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
    Zhou L; Askew D; Wu C; Gilliam AC
    J Invest Dermatol; 2007 Feb; 127(2):281-92. PubMed ID: 16917493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.
    Mapara MY; Leng C; Kim YM; Bronson R; Lokshin A; Luster A; Sykes M
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):623-34. PubMed ID: 16737935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.
    Eyrich M; Burger G; Marquardt K; Budach W; Schilbach K; Niethammer D; Schlegel PG
    Biol Blood Marrow Transplant; 2005 May; 11(5):371-82. PubMed ID: 15846291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.
    Lim JY; Ryu DB; Lee SE; Park G; Min CK
    J Invest Dermatol; 2017 Sep; 137(9):1895-1904. PubMed ID: 28526296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation.
    Jaksch M; Remberger M; Mattsson J
    Biol Blood Marrow Transplant; 2005 Apr; 11(4):280-7. PubMed ID: 15812393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.
    Faaij CM; Lankester AC; Spierings E; Hoogeboom M; Bowman EP; Bierings M; Révész T; Egeler RM; van Tol MJ; Annels NE
    Br J Haematol; 2006 Jun; 133(5):538-49. PubMed ID: 16681643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of cutaneous TNFalpha-producing CD4+ T cells and TNFalpha may allow for fibrosis rather than epithelial cytotoxicity in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
    Askew D; Zhou L; Wu C; Chen G; Gilliam AC
    J Invest Dermatol; 2007 Aug; 127(8):1905-14. PubMed ID: 17429441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
    Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
    Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling of major histocompatibility and natural killer complex genes reveals candidates for controlling risk of graft versus host disease.
    Novota P; Zinöcker S; Norden J; Wang XN; Sviland L; Opitz L; Salinas-Riester G; Rolstad B; Dickinson AM; Walter L; Dressel R
    PLoS One; 2011 Jan; 6(1):e16582. PubMed ID: 21305040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
    Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
    Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the pathogenesis of GvHD: what mice can teach us about man.
    Hülsdünker J; Zeiser R
    Tissue Antigens; 2015 Jan; 85(1):2-9. PubMed ID: 25532439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease.
    New JY; Li B; Koh WP; Ng HK; Tan SY; Yap EH; Chan SH; Hu HZ
    Bone Marrow Transplant; 2002 Jun; 29(12):979-86. PubMed ID: 12098066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
    Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
    Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.